Literature DB >> 359493

Pharmacokinetics of antimalarials and proposals for dosage regimens.

W A Ritschel, G V Hammer, G A Thompson.   

Abstract

Blood level data for the antimalarials amodiaquine, chloroguanide, chloroquine, pyrimethamine, quinine and sulphadoxine have been retrieved from the literature and pharmacokinetically analyzed. Minimum, average and maximum blood level concentrations at steady state in suppressive treatment and peak concentrations in therapeutic treatment were predicted and blood level-time curves simulated. Based on the computer-predicted data, changes in dosage regimens are proposed to reduce the fluctuations between maximum and minimum levels in suppressive treatment, and for obtaining maximum peak levels in therapeutic treatment already with the loading dose.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 359493

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Biopharm        ISSN: 0340-0026


  5 in total

1.  Steady state disposition of chloroquine in patients with rheumatoid disease.

Authors:  M Frisk-Holmberg; Y Bergqvist; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.

Authors:  M Frisk-Holmberg; Y Bergqvist; E Termond; B Domeij-Nyberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 3.  Clinical features and management of poisoning due to antimalarial drugs.

Authors:  A Jaeger; P Sauder; J Kopferschmitt; F Flesch
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

Review 4.  Malaria prophylaxis in travellers: the current position.

Authors:  D Stürchler
Journal:  Experientia       Date:  1984-12-15

5.  A study of the effects of amodiaquine on the guinea-pig isolated ileum.

Authors:  J Fontaine; J P Famaey; J Reuse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.